COPS7A expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.578000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.897200E-01
Normal-vs-Stage2
7.881200E-01
Normal-vs-Stage3
9.131600E-01
Normal-vs-Stage4
3.978400E-01
Stage1-vs-Stage2
8.599800E-01
Stage1-vs-Stage3
9.774800E-01
Stage1-vs-Stage4
5.066000E-01
Stage2-vs-Stage3
9.256400E-01
Stage2-vs-Stage4
8.163600E-01
Stage3-vs-Stage4
8.506400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.316400E-01
Normal-vs-AfricanAmerican
7.926000E-01
Normal-vs-Asian
7.181800E-01
Caucasian-vs-AfricanAmerican
3.235800E-02
Caucasian-vs-Asian
2.514800E-01
AfricanAmerican-vs-Asian
6.412400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.623000E-01
Normal-vs-Female
7.513200E-01
Male-vs-Female
9.324000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.408600E-01
Normal-vs-Age(41-60Yrs)
6.214200E-01
Normal-vs-Age(61-80Yrs)
8.494800E-01
Normal-vs-Age(81-100Yrs)
5.601200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.519400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.347000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.853200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.623000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.573400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.171000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.871600E-01
Normal-vs-Daily Drinker
8.555800E-01
Normal-vs-Weekly Drinker
7.706800E-01
Normal-vs-Occasional Drinker
3.274000E-01
Normal-vs-Social Drinker
6.234400E-01
Non Drinker-vs-Daily Drinker
5.378600E-01
Non Drinker-vs-Weekly Drinker
9.248400E-01
Non Drinker-vs-Occasional Drinker
3.348600E-01
Non Drinker-vs-Social Drinker
4.549600E-01
Daily Drinker-vs-Weekly Drinker
4.190200E-01
Daily Drinker-vs-Occasional Drinker
1.788370E-02
Daily Drinker-vs-Social Drinker
2.295400E-01
Weekly Drinker-vs-Occasional Drinker
3.546400E-01
Weekly Drinker-vs-Social Drinker
5.136800E-01
Occasional Drinker-vs-Social Drinker
9.083000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.091600E-01
Normal-vs-Grade 2
1.228810E-01
Normal-vs-Grade 3
1.400400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.273000E-01
Grade 1-vs-Grade 3
8.346800E-01
Grade 1-vs-Grade 4
2.091600E-01
Grade 2-vs-Grade 3
1.819050E-01
Grade 2-vs-Grade 4
1.228810E-01
Grade 3-vs-Grade 4
1.400400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.259800E-01
Normal-vs-NonDiabetic
7.057800E-01
Diabetic-vs-NonDiabetic
5.870800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.950400E-01
Normal-vs-NoPancreatitis
8.072200E-01
Pancreatitis-vs-NoPancreatitis
5.706400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.798200E-01
Normal-vs-N1
8.181800E-01
N0-vs-N1
3.021800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.213800E-01
Normal-vs-TP53-NonMutant
8.011800E-01
TP53-Mutant-vs-TP53-NonMutant
2.857800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
